Inspire Medical Systems Return on Investment 2017-2025 | INSP
Current and historical return on investment (ROI) values for Inspire Medical Systems (INSP) over the last 10 years.
| Inspire Medical Systems ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2025-03-31 | $0.05B | 0.00% | |
| 2024-12-31 | $0.04B | 0.00% | |
| 2024-09-30 | $0.01B | 0.00% | |
| 2024-06-30 | $-0.01B | 0.00% | |
| 2024-03-31 | $-0.04B | 0.00% | |
| 2023-12-31 | $-0.04B | 0.00% | |
| 2023-09-30 | $-0.05B | 0.00% | |
| 2023-06-30 | $-0.05B | 0.00% | |
| 2023-03-31 | $-0.05B | -84.39% | |
| 2022-12-31 | $-0.05B | -39.58% | |
| 2022-09-30 | $-0.05B | -27.22% | |
| 2022-06-30 | $-0.04B | $0.24B | -17.52% |
| 2022-03-31 | $-0.04B | $0.24B | -17.01% |
| 2021-12-31 | $-0.04B | $0.25B | -16.84% |
| 2021-09-30 | $-0.05B | $0.24B | -18.72% |
| 2021-06-30 | $-0.05B | $0.24B | -18.44% |
| 2021-03-31 | $-0.06B | $0.25B | -22.09% |
| 2020-12-31 | $-0.06B | $0.25B | -24.40% |
| 2020-09-30 | $-0.06B | $0.25B | -28.02% |
| 2020-06-30 | $-0.06B | $0.26B | -30.60% |
| 2020-03-31 | $-0.04B | $0.15B | -25.30% |
| 2019-12-31 | $-0.04B | $0.16B | -20.17% |
| 2019-09-30 | $-0.03B | $0.17B | -17.25% |
| 2019-06-30 | $-0.03B | $0.18B | -16.10% |
| 2019-03-31 | $-0.03B | $0.18B | -16.16% |
| 2018-12-31 | $-0.02B | $0.19B | -18.42% |
| 2018-09-30 | $-0.02B | $0.12B | -28.07% |
| 2018-06-30 | $-0.02B | $0.13B | -46.91% |
| 2018-03-31 | $-0.02B | $0.02B | -183.78% |
| 2017-12-31 | $-0.02B | $0.02B | -355.56% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $4.007B | $0.803B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.172B | 60.28 |
| Hims & Hers Health (HIMS) | United States | $11.812B | 122.72 |
| Tempus AI (TEM) | United States | $10.155B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.637B | 0.00 |
| Hinge Health (HNGE) | United States | $3.004B | 0.00 |
| Privia Health (PRVA) | United States | $2.780B | 190.00 |
| Enovis (ENOV) | United States | $1.805B | 10.06 |
| Schrodinger (SDGR) | United States | $1.749B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.537B | 0.00 |
| Phreesia (PHR) | United States | $1.534B | 0.00 |
| Omnicell (OMCL) | United States | $1.446B | 25.51 |
| Azenta (AZTA) | United States | $1.296B | 60.21 |
| 10x Genomics (TXG) | United States | $1.122B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.634B | 0.00 |
| Claritev (CTEV) | United States | $0.631B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.581B | 0.00 |
| Talkspace (TALK) | United States | $0.544B | 162.50 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Standard BioTools (LAB) | United States | $0.378B | 0.00 |
| Outset Medical (OM) | United States | $0.356B | 0.00 |
| TruBridge (TBRG) | United States | $0.353B | 784.00 |
| Health Catalyst (HCAT) | United States | $0.267B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.135B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.124B | 0.00 |
| Pulmonx (LUNG) | United States | $0.120B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.098B | 0.00 |
| CareCloud (CCLD) | United States | $0.091B | 3.48 |
| 111 (YI) | China | $0.072B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.047B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.032B | 0.00 |
| Zhongchao (ZCMD) | China | $0.027B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |